Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zevalin + BEAM in Relapsed/Refractory NHL
NCT00438581Phase 2Unknown
- Sponsor
- McGill University
- Start
- Mar 2007
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ibritumomab tiuxetan in non-Hodgkin lymphoma (NHL), sponsored by McGill University. Status: unknown.
02
Drugs
ibritumomab tiuxetan
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00438581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00438581.